Merck & Co., Inc. is 41.2x more valuable than TG THERAPEUTICS, INC. by market capitalization ($294.13 B vs $7.14 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TGTX | MRK |
|---|---|---|
| Market cap | $7.14 B | $294.13 B |
| US-listed rank | #1140 | #44 |
| Revenue (latest FY) | $616.29M | $65.01B |
| Net income (latest FY) | $447.20M | $18.25B |
| Net margin | 72.6% | 28.1% |
| P/E (trailing FY) | 16.0 | 16.1 |
| SEC filings | 1,133 | 996 |
Merck & Co., Inc. is 41.2x more valuable than TG THERAPEUTICS, INC. by market capitalization ($294.13 B vs $7.14 B).
In their latest fiscal years, TG THERAPEUTICS, INC. reported $616.29M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: TG THERAPEUTICS, INC. and Merck & Co., Inc., or browse the full rankings.